Cutera (NASDAQ:CUTR) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued on Wednesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Trading Down 0.2 %

Shares of NASDAQ:CUTR opened at $0.41 on Wednesday. The stock has a 50 day moving average of $0.41 and a 200 day moving average of $0.68. The company has a market cap of $8.34 million, a PE ratio of -0.06 and a beta of 1.31. Cutera has a 12-month low of $0.28 and a 12-month high of $3.10.

Cutera (NASDAQ:CUTR) last posted its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.94) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.96) by ($0.98). The business had revenue of $32.50 million for the quarter, compared to analyst estimates of $32.57 million. During the same period in the prior year, the firm posted ($2.22) EPS. Equities research analysts predict that Cutera will post -5.78 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Bank of Montreal Can grew its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 14.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 282,704 shares of the medical device company’s stock after acquiring an additional 35,248 shares during the quarter. Bank of Montreal Can owned about 1.41% of Cutera worth $455,000 at the end of the most recent reporting period. 90.70% of the stock is currently owned by institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.